Evidence map›Paper›PMID 32008155›Full record

ArticleClinical rheumatology2020

The role of socioeconomic status in the susceptibility to develop systemic lupus erythematosus in Mexican patients.

Norma Alicia Salgado-Galicia, Susana Hernández-Doño, Daniela Ruiz-Gómez, Juan Jakez-Ocampo, Joaquín Zúñiga, Gilberto Vargas-Alarcón, Víctor Acuña, María Teresa Hernández, José Eduardo Márquez-García, Maricela García-Lechuga and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical rheumatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus.International journal of molecular sciences · 2023
    Review
  3. A Contemporary Update on the Diagnosis of Systemic Lupus Erythematosus.Clinical reviews in allergy & immunology · 2022
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Norma Alicia Salgado-GaliciaTransplant Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-2617-9286
Susana Hernández-DoñoTransplant Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-6949-7081
Daniela Ruiz-GómezFundación Clínica Médica Sur A.C, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-8110-2214
Juan Jakez-OcampoImmunology and Rheumatology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-8862-1201
Joaquín ZúñigaLaboratory of Immunobiology and Genetics, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-7143-0281
Gilberto Vargas-AlarcónDirección de Investigación, Instituto Nacional de Cardiología Ignacio Chávez, Mexico City, Mexico.ORCID https://orcid.org/0000-0001-7916-5163
Víctor AcuñaEscuela Nacional de Antropología e Historia (ENAH), Mexico City, Mexico.
María Teresa HernándezNutrition Institute, Universidad de la Sierra Sur, Miahuatlán de Porfirio Díaz, Oaxaca, Mexico.ORCID https://orcid.org/0000-0003-3475-8816
José Eduardo Márquez-GarcíaMolecular Biology Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.ORCID https://orcid.org/0000-0003-2172-0114
Maricela García-LechugaCentro Médico Nacional Adolfo Ruíz Cortínez, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-0981-1905
Luis LlorenteImmunology and Rheumatology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-3464-3747
Guadalupe LimaImmunology and Rheumatology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-0736-8292
Carlos PinedaInvestigador Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City, Mexico.ORCID https://orcid.org/0000-0003-0544-7461
Neng YuHLA Laboratory, The American Red Cross Northeast Division, Dedham, MA, USA.
Edmond YunisDepartment of Cancer Immunology and AIDS, Dana Farber Cancer Institute, Boston, MA, USA.
Julio GranadosTransplant Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. julgrate@yahoo.com.ORCID https://orcid.org/0000-0001-8553-1027

Funding

Consejo Nacional de Ciencia y Tecnología de México (CONACYT) 000 000 000273175
6 · The paper itself

Abstract

introductionSystemic lupus erythematosus (SLE) is an autoimmune inflammatory disorder for which Major Histocompatibility Complex (MHC) genes are well-identified as risk factors. SLE patients have different phenotypes or clinical presentations, which vary among Mexicans. This variation could be explained by ethnicity and admixture. Since socioeconomic status probably limits and change the patterns of migration, this factor could favor inbreeding and homogamy in some geographic areas. Consequently, it could alter or restrict the possibilities of admixture too. Therefore, the socioeconomic status may also have implications in the susceptibility and the clinical heterogeneity of SLE in Mexican patients.

methodsOne hundred twenty-three SLE patients and 234 healthy individuals with Mexican admixed ancestry were recruited. HLA alleles were analyzed using the HLA typing method based on Sequence-based typing (SBT).

resultsAs expected, it was found an increased frequency of the HLA-DRB1*03:01 allele in all socioeconomic groups when compared with healthy individuals. The susceptibility allele found in the low-income SLE patients was HLA-DRB1*04:05 whereas, the susceptibility alleles for the high-income SLE patients were HLA-DRB1*07:01 (pC = 0.03, OR = 2.0) and HLA-DRB1*11:04 (pC = 0.0004, OR = 5.1). Additionally, the frequencies of two protective alleles HLA-DRB1*14:06 (pC = 0.01, OR = 0.28) and HLA-DRB1*16:02 (pC = 0.04, OR = 0.22) were found diminished. These findings correlate with the admixture differences between low-income and high-income SLE patients. The clinical manifestations showed a different distribution between both groups. Arthritis and neurological disorder were prevalent in low-income SLE patients, while the hematological disorder was prevalent in high-income SLE patients.

conclusionsThese findings suggest that HLA class II DRB1 genes contribute to the susceptibility and protection to develop SLE differently depending on socioeconomic status. Due to this, the clinical manifestations vary among patients and it could be related to different admixture charge.Key Point• HLA class II DRB1 genes contribute to the susceptibility and protection to develop SLE differently depending on socioeconomic status.

Indexed as

Genetic Predisposition to DiseaseIncomeSocial ClassAdultAllelesCase-Control StudiesFemaleHLA-DRB1 ChainsHumansLupus Erythematosus, SystemicMaleMexicoMiddle AgedPhenotypeYoung AdultHLA-DRB1 ChainsHigh-incomeHLA-DRB1 allelesLow-incomeSystemic lupus erythematosus

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.